Tal Gilboa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tal Gilboa has a total of 181 co-authors. Here are the top co-authors by number of shared publications:
Mohammad Kurd
Pediatric neurology unit, Hadassah medical center, Jerusalem, Israel
3 shared publicationsBruria Ben Zeev
Pediatric Neurology Unit, Safra Children's Hospital, Sheba Medical Center, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel
2 shared publicationsAbbe Lai
Division of Genetics and Genomics, Department of Pediatrics Boston Children's Hospital Boston Massachusetts USA
1 shared publicationAbdullah M. Tamim
Pediatric Neurology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
1 shared publication- Adam Claridge-Chang
Duke-NUS Medical School, Singapore
1 shared publication Adel A. H. Mahmoud
Pediatric Neurology Department, National Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia
1 shared publication
Latest Publications
- 25 September 2026
- Published by BMJ in Archives of Disease in Childhood
Coming wave of subacute sclerosing panencephalitis: a call for a global registry
- 25 September 2026
- Published by BMJ in Archives of Disease in Childhood
Coming wave of subacute sclerosing panencephalitis: a call for a global registry
- Open Access
- 10 September 2026
- Published by Elsevier in Neuroimage: Reports
- Vol. 6 (4)
Functional near-infrared spectroscopy pre-ictal oscillations recorded simultaneously with stereo-EEG
- 10 September 2026
- Published by Elsevier in Neuroimage: Reports
- Vol. 6 (4)
Open AccessFunctional near-infrared spectroscopy pre-ictal oscillations recorded simultaneously with stereo-EEG
- 5 May 2026
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 62, 14-21
Adjunctive cenobamate in children and adolescents – real-world data from a retrospective multicenter study
- 5 May 2026
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 62, 14-21
Adjunctive cenobamate in children and adolescents – real-world data from a retrospective multicenter study
- 10 March 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 137, 152-157
Epilepsy severity, parental knowledge, and health-related quality of life in children with epilepsy and their parents
- 10 March 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 137, 152-157
Epilepsy severity, parental knowledge, and health-related quality of life in children with epilepsy and their parents
- Open Access
- 1 September 2025
- Published by Wiley in European Journal of Neurology
- Vol. 32 (9) , e70288
Does the Timing of Electroencephalogram Recording After a First Unprovoked Seizure Influence Its Ability to Predict Additional Seizures?
Background: Abnormal electroencephalograms (EEGs) are a known risk factor for additional seizures following a first unprovoked seizure (FUS). This study assessed whether early or late EEGs after a FUS predict subsequent seizures in pediatric and adult patients.Methods: This retrospective study included patients who underwent EEGs after a FUS between 4/2011 and 12/2015, categorized into children (≤ 16 years) and adults. EEGs (assigned as generally abnormal or specifically epileptiform) performed early (within 2 days) or later were correlated with patient characteristics, anti‐seizure medication (ASM) use, and additional seizures within 2 years.Results: The study involved 202 participants (137 children, 65 adults) with 168 early and 127 late EEGs. Children had more abnormal early and late EEGs than adults, though early EEGs were conducted sooner in adults. More early EEGs in children showed epileptiform activity. ASMs were more frequently prescribed in adults, patients with risk factors, and those with abnormal early EEGs, but ASM use did not correlate with less abnormal late EEGs. Epileptiform activity in late EEGs (p = 0.006, OR 3.085) and ASM use (p = 0.018, OR 0.39) were significantly linked to additional seizures on multivariate analysis, with similar findings in pediatric but not adult patients.Conclusions: Both early and late EEGs are valuable following a FUS, serving different purposes. Early EEGs are helpful for diagnosis, while late EEGs offer better prognostic value for seizure recurrence. Further research is needed to confirm these results in larger, prospective studies.
- 1 September 2025
- Published by Wiley in European Journal of Neurology
- Vol. 32 (9) , e70288
Open AccessDoes the Timing of Electroencephalogram Recording After a First Unprovoked Seizure Influence Its Ability to Predict Additional Seizures?
Background: Abnormal electroencephalograms (EEGs) are a known risk factor for additional seizures following a first unprovoked seizure (FUS). This study assessed whether early or late EEGs after a FUS predict subsequent seizures in pediatric and adult patients.Methods: This retrospective study included patients who underwent EEGs after a FUS between 4/2011 and 12/2015, categorized into children (≤ 16 years) and adults. EEGs (assigned as generally abnormal or specifically epileptiform) performed early (within 2 days) or later were correlated with patient characteristics, anti‐seizure medication (ASM) use, and additional seizures within 2 years.Results: The study involved 202 participants (137 children, 65 adults) with 168 early and 127 late EEGs. Children had more abnormal early and late EEGs than adults, though early EEGs were conducted sooner in adults. More early EEGs in children showed epileptiform activity. ASMs were more frequently prescribed in adults, patients with risk factors, and those with abnormal early EEGs, but ASM use did not correlate with less abnormal late EEGs. Epileptiform activity in late EEGs (p = 0.006, OR 3.085) and ASM use (p = 0.018, OR 0.39) were significantly linked to additional seizures on multivariate analysis, with similar findings in pediatric but not adult patients.Conclusions: Both early and late EEGs are valuable following a FUS, serving different purposes. Early EEGs are helpful for diagnosis, while late EEGs offer better prognostic value for seizure recurrence. Further research is needed to confirm these results in larger, prospective studies.
- 15 March 2024
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 50, 1-5
Autoimmune encephalitis in Israeli children – A retrospective nationwide study
- 15 March 2024
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 50, 1-5
Autoimmune encephalitis in Israeli children – A retrospective nationwide study
- 23 January 2024
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 49, 13-16
Validation of the 2023 international diagnostic criteria for MOGAD in a pediatric cohort
- 23 January 2024
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 49, 13-16
Validation of the 2023 international diagnostic criteria for MOGAD in a pediatric cohort
- Open Access
- 9 August 2023
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 31 (10) , 1190-1194
Novel homozygous variants in PRORP expand the genotypic spectrum of combined oxidative phosphorylation deficiency 54
Biallelic hypomorphic variants in PRORP have been recently described as causing the autosomal recessive disorder combined oxidative phosphorylation deficiency type 54 (COXPD54). COXPD54 encompasses a phenotypic spectrum of sensorineural hearing loss and ovarian insufficiency (Perrault syndrome) to leukodystrophy. Here, we report three additional families with homozygous missense PRORP variants with pleiotropic phenotypes. Each missense variant altered a highly conserved residue within the metallonuclease domain. In vitro mitochondrial tRNA processing assays with recombinant TRMT10C, SDR5C1 and PRORP indicated two COXPD54-associated PRORP variants, c.1159A>G (p.Thr387Ala) and c.1241C>T (p.Ala414Val), decreased pre-tRNAIle cleavage, consistent with both variants impacting tRNA processing. No significant decrease in tRNA processing was observed with PRORP c.1093T>C (p.Tyr365His), which was identified in an individual with leukodystrophy. These data provide independent evidence that PRORP variants are associated with COXPD54 and that the assessment of 5′ leader mitochondrial tRNA processing is a valuable assay for the functional analysis and clinical interpretation of novel PRORP variants.
- 9 August 2023
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 31 (10) , 1190-1194
Open AccessNovel homozygous variants in PRORP expand the genotypic spectrum of combined oxidative phosphorylation deficiency 54
Biallelic hypomorphic variants in PRORP have been recently described as causing the autosomal recessive disorder combined oxidative phosphorylation deficiency type 54 (COXPD54). COXPD54 encompasses a phenotypic spectrum of sensorineural hearing loss and ovarian insufficiency (Perrault syndrome) to leukodystrophy. Here, we report three additional families with homozygous missense PRORP variants with pleiotropic phenotypes. Each missense variant altered a highly conserved residue within the metallonuclease domain. In vitro mitochondrial tRNA processing assays with recombinant TRMT10C, SDR5C1 and PRORP indicated two COXPD54-associated PRORP variants, c.1159A>G (p.Thr387Ala) and c.1241C>T (p.Ala414Val), decreased pre-tRNAIle cleavage, consistent with both variants impacting tRNA processing. No significant decrease in tRNA processing was observed with PRORP c.1093T>C (p.Tyr365His), which was identified in an individual with leukodystrophy. These data provide independent evidence that PRORP variants are associated with COXPD54 and that the assessment of 5′ leader mitochondrial tRNA processing is a valuable assay for the functional analysis and clinical interpretation of novel PRORP variants.
- Open Access
- 2 April 2023
- Published by Wiley in Clinical Genetics
- Vol. 104 (1) , 73-80
A recurrent de novo variant in NUSAP1 escapes nonsense‐mediated decay and leads to microcephaly, epilepsy, and developmental delay
NUSAP1 encodes a cell cycle-dependent protein with key roles in mitotic progression, spindle formation, and microtubule stability. Both over- and under-expression of NUSAP1 lead to dysregulation of mitosis and impaired cell proliferation. Through exome sequencing and Matchmaker Exchange, we identified two unrelated individuals with the same recurrent, de novo heterozygous variant (NM_016359.5 c.1209C > A; p.(Tyr403Ter)) in NUSAP1. Both individuals had microcephaly, severe developmental delay, brain abnormalities, and seizures. The gene is predicted to be tolerant of heterozygous loss-of-function mutations, and we show that the mutant transcript escapes nonsense mediated decay, suggesting that the mechanism is likely dominant-negative or toxic gain of function. Single-cell RNA-sequencing of an affected individual's post-mortem brain tissue indicated that the NUSAP1 mutant brain contains all main cell lineages, and that the microcephaly could not be attributed to loss of a specific cell type. We hypothesize that pathogenic variants in NUSAP1 lead to microcephaly possibly by an underlying defect in neural progenitor cells.
- 2 April 2023
- Published by Wiley in Clinical Genetics
- Vol. 104 (1) , 73-80
Open AccessA recurrent de novo variant in NUSAP1 escapes nonsense‐mediated decay and leads to microcephaly, epilepsy, and developmental delay
NUSAP1 encodes a cell cycle-dependent protein with key roles in mitotic progression, spindle formation, and microtubule stability. Both over- and under-expression of NUSAP1 lead to dysregulation of mitosis and impaired cell proliferation. Through exome sequencing and Matchmaker Exchange, we identified two unrelated individuals with the same recurrent, de novo heterozygous variant (NM_016359.5 c.1209C > A; p.(Tyr403Ter)) in NUSAP1. Both individuals had microcephaly, severe developmental delay, brain abnormalities, and seizures. The gene is predicted to be tolerant of heterozygous loss-of-function mutations, and we show that the mutant transcript escapes nonsense mediated decay, suggesting that the mechanism is likely dominant-negative or toxic gain of function. Single-cell RNA-sequencing of an affected individual's post-mortem brain tissue indicated that the NUSAP1 mutant brain contains all main cell lineages, and that the microcephaly could not be attributed to loss of a specific cell type. We hypothesize that pathogenic variants in NUSAP1 lead to microcephaly possibly by an underlying defect in neural progenitor cells.
- 29 November 2022
- Published by Springer Nature in neurogenetics
- Vol. 24 (1) , 61-66
Delineating the phenotype and genetic basis of AMPD2-related pontocerebellar hypoplasia
Pontocerebellar hypoplasia is a group of disorders with a wide range of presentations. We describe here the genetic and phenotypic features of PCH type 9 due to mutations in AMPD2. All patients have severe intellectual disability, and the vast majority manifest abnormal tone, cortical blindness, and microcephaly. Almost all have agenesis of the corpus callosum and severe cerebellar hypoplasia. The course is not progressive, however, few die in the first decade of life. Mutations are spread throughout the gene, and no hot spot can be identified. One of the mutations we report here is the most distal truncating variant known in this gene and is predicted to result in a truncated protein. The phenotype is severe in all cases; thus, no clear genotype–phenotype correlation can be established.
- 29 November 2022
- Published by Springer Nature in neurogenetics
- Vol. 24 (1) , 61-66
Delineating the phenotype and genetic basis of AMPD2-related pontocerebellar hypoplasia
Pontocerebellar hypoplasia is a group of disorders with a wide range of presentations. We describe here the genetic and phenotypic features of PCH type 9 due to mutations in AMPD2. All patients have severe intellectual disability, and the vast majority manifest abnormal tone, cortical blindness, and microcephaly. Almost all have agenesis of the corpus callosum and severe cerebellar hypoplasia. The course is not progressive, however, few die in the first decade of life. Mutations are spread throughout the gene, and no hot spot can be identified. One of the mutations we report here is the most distal truncating variant known in this gene and is predicted to result in a truncated protein. The phenotype is severe in all cases; thus, no clear genotype–phenotype correlation can be established.